RvD1 inhibits the secretion of a cartilage oligomeric matrix protein (COMP) by targeting FPR1/ROS/ROXM1 signaling, thereby impeding the cancer stem-like properties and EMT of hepatocellular carcinoma cells [101]. Here, COMP is linked to cancer.